Peroxisomal Disorders (Zellweger Syndrome Spectrum)
What is Peroxisomal Disorders (Zellweger Syndrome Spectrum)?
Peroxisomal disorders are rare genetic conditions that affect how your body breaks down fats and builds important molecules. Peroxisomes are tiny structures inside your cells that do hundreds of essential jobs. They help your body process very long chain fatty acids, create certain types of fats needed for your brain, and remove toxic substances.
Zellweger syndrome spectrum describes a group of peroxisomal disorders that range from severe to milder forms. The most severe form is classic Zellweger syndrome, which affects multiple organs from birth. Milder forms include neonatal adrenoleukodystrophy and infantile Refsum disease. All forms are caused by mutations in genes that build and maintain peroxisomes.
When peroxisomes do not work properly, harmful fats build up in your body and brain. Your body also cannot make enough DHA, an omega-3 fatty acid critical for brain and eye development. These disorders are inherited in an autosomal recessive pattern, meaning both parents must carry the gene mutation for a child to be affected.
Symptoms
- Poor muscle tone and weakness in infants
- Feeding difficulties and failure to gain weight
- Distinctive facial features including high forehead and broad nasal bridge
- Seizures that may begin in infancy
- Vision problems or blindness
- Hearing loss
- Liver enlargement and dysfunction
- Developmental delays or loss of developmental milestones
- Brain abnormalities visible on imaging
- Kidney cysts or other organ malformations
Symptoms typically appear in the first months of life for severe forms. Milder forms may not show symptoms until later in childhood. The severity and combination of symptoms varies widely across the spectrum.
Concerned about Peroxisomal Disorders (Zellweger Syndrome Spectrum)? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Peroxisomal disorders are caused by mutations in genes that control peroxisome formation and function. Over 13 different genes can cause Zellweger syndrome spectrum disorders. These genes provide instructions for making proteins called peroxins, which are needed to build working peroxisomes. When these genes are mutated, peroxisomes either do not form at all or cannot do their jobs properly.
These conditions follow an autosomal recessive inheritance pattern. Both parents must carry one copy of the mutated gene for their child to be affected. Carrier parents typically have no symptoms themselves. There are no lifestyle or environmental risk factors that cause these genetic mutations, though certain populations may have higher carrier rates for specific mutations.
How it's diagnosed
Peroxisomal disorders are diagnosed through a combination of clinical evaluation, blood tests, and genetic testing. Blood tests measure very long chain fatty acids, which are elevated in these conditions. DHA levels are typically very low because peroxisomes are needed to make this important omega-3 fatty acid. Other blood markers include phytanic acid and plasmalogen levels.
Rite Aid offers DHA testing as an add-on to our blood test panel. Low DHA levels can be an important early clue in diagnosing peroxisomal disorders. If results suggest a peroxisomal disorder, your doctor will order additional specialized testing including genetic analysis to confirm the diagnosis and identify the specific gene mutation involved.
Treatment options
- DHA supplementation to address deficiency and support brain development
- Specialized formulas and feeding support for infants with feeding difficulties
- Physical therapy to help with muscle tone and motor skills
- Occupational therapy to support daily functioning
- Medications to control seizures
- Hearing aids or cochlear implants for hearing loss
- Vision aids and support services for visual impairment
- Liver support and monitoring for liver dysfunction
- Nutritional support tailored to individual needs
- Regular monitoring by a team of specialists including geneticists, neurologists, and other experts
Need testing for Peroxisomal Disorders (Zellweger Syndrome Spectrum)? Add it to your panel.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
Peroxisomal disorders are rare genetic conditions where tiny cell structures called peroxisomes do not work properly. These disorders affect how your body breaks down certain fats and makes important molecules needed for brain and nerve function. The Zellweger syndrome spectrum includes the most severe forms of peroxisomal disorders.
Peroxisomal disorders are very rare, affecting approximately 1 in 50,000 to 1 in 100,000 births. Zellweger syndrome spectrum disorders represent the most common type of peroxisomal disorder. Because they are so rare, many healthcare providers may never see a case during their career.
Yes, newborn screening programs in some states include tests that can detect peroxisomal disorders before symptoms develop. Blood tests measuring DHA and very long chain fatty acids can reveal problems early. Early detection allows families to begin supportive care and monitoring right away.
DHA is an omega-3 fatty acid that your body makes inside peroxisomes. When peroxisomes do not work, DHA levels drop very low. Measuring DHA in blood is one of the key screening tests for peroxisomal disorders and helps doctors identify affected children early.
No, peroxisomal disorders exist on a spectrum from severe to milder forms. Classic Zellweger syndrome is the most severe and affects multiple organs from birth. Milder forms like infantile Refsum disease may allow children to survive longer and have less severe symptoms.
There is currently no cure for peroxisomal disorders. Treatment focuses on managing symptoms and providing supportive care. DHA supplementation can help address one key deficiency, but it does not fix the underlying genetic problem with peroxisome function.
Peroxisomal disorders follow an autosomal recessive inheritance pattern. This means both parents must carry a mutated gene for their child to be affected. Parents who are carriers typically have no symptoms and may not know they carry the mutation until they have an affected child.
Life expectancy varies widely across the Zellweger syndrome spectrum. Children with classic Zellweger syndrome typically do not survive beyond their first year of life. Children with milder forms may survive into childhood or adolescence with appropriate supportive care.
Yes, genetic counseling is strongly recommended for families affected by peroxisomal disorders. A genetic counselor can explain the 25% recurrence risk for each future pregnancy. They can also discuss options like prenatal testing or preimplantation genetic diagnosis for future pregnancies.
Classic peroxisomal disorders like Zellweger syndrome appear in infancy or early childhood. However, some milder peroxisomal conditions may not be diagnosed until adulthood. Adults with unexplained neurological symptoms and low DHA levels should discuss peroxisomal testing with their doctor.